Sodium Glycididazole

DRUG5 trials

Sponsors

Shandong Luye Pharmaceutical Co., Ltd., Shandong Cancer Hospital and Institute, Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions

ChemoradiotherapyEsophageal CarcinomaEsophageal Neoplasms

Phase 2

Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy

RecruitingNCT06667622

Cancer Institute and Hospital, Chinese Academy of Medical SciencesChemoradiotherapy

Start: 2024-05-29End: 2026-07-20Target: 40Updated: 2024-10-31

Phase 4

A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma

Shandong Luye Pharmaceutical Co., Ltd.Esophageal Carcinoma

Start: 2008-04-30End: 2009-12-31Target: 48Updated: 2008-05-14

A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC

TerminatedNCT02721576

Shandong Cancer Hospital and InstituteEsophageal Neoplasms

Start: 2016-07-05End: 2018-07-30Updated: 2019-10-11

A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC

CompletedNCT02721563

Shandong Cancer Hospital and InstituteEsophageal Neoplasms

Start: 2016-02-25End: 2018-06-30Updated: 2019-10-11

A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC

TerminatedNCT02721550

Shandong Cancer Hospital and InstituteEsophageal Neoplasms

Start: 2016-08-01End: 2018-06-30Updated: 2019-10-11